The scope excludes over-the-counter supplements, compounded drug products, delivery device revenues separable from pharmaceutical value, and biosimilars not yet approved in major regulated markets
Combination-therapy models: Evaluating interactions with GLP-1 receptor agonists (e.g., semaglutide) to study additive or complementary effects on appetite and metabolism
PCa has shown limited response to immunotherapy because of its cold tumor environment
Research suggests that glutathione inhibits the enzyme tyrosinase, which reduces melanin production, leading to brighter and even-toned skin
Of 124 station survey respondents, most reported that NAFLD patients were managed in hepatology/GI (68, 55%) or in primary care (61, 50%)
Insurers have plenty to consider when weighing coverage for new weight loss medications, and that includes the need to carefully coordinate distribution with their pharmacy benefit managers, according to a new playbook